Compatible with the most popular GLP-1 peptides: Wegovy, Zepbound, Ozempic, Mounjaro, Foundayo, semaglutide, tirzepatide, liraglutide, dulaglutide, retatrutide, MariTide, VK2735, BPC-157, TB-500, and 100+ more
Personalized treatment modifications tailored to each patient
By increasing visceral fat oxidation, certain injectable peptides for weight loss can reduce abdominal fat stores more effectively than diet alone
Unmet Needs and Whitespace Opportunities Despite the remarkable clinical and commercial success of GLP-1 agonists, significant unmet needs persist that define the whitespace for next-generation innovation
The pharmacokinetic and pharmacodynamic characteristics of different GLP-1 RAs may be relevant (Shu et al., 2022)